The DEDICATE-DZHK6 is a non-industry sponsored randomized noninferiority trial conducted at 38 sites in Germany, where patients with severe aortic stenosis who were at low or intermediate surgical risk were randomly assigned to undergo either transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR).
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cardiac
May 29, 2024
In this recent paper, the authors set out to describe trends and outcomes for patients undergoing surgical aortic valve replacement in the Netherlands. They utilized the Netherlands Heart Registration database to analyze cases completed between 2007 and 2018.
May 29, 2024
This video demonstrates repair of a chronically dissected ascending aortic aneurysm.
May 28, 2024
ERAS Cardiac Society conducted a joint webinar with CTSNet on May 23, 2024, bringing about pivotal insights and questions on the topic, "Post Operative Complications Following Cardiac Surgery and Their Clinical Impact." The session included presentations from Dr. Andrew D. Shaw and Dr. Rakesh C. Arora, with Dr. Daniel Engelman and Dr.
May 28, 2024
This operative video demonstrates repair of the left main coronary ostial atresia in an infant.
May 27, 2024
The authors demonstrate their technique for left innominate vein cannulation for mitral valve surgery.
May 24, 2024
This video details a simple and reproducible technique for safe sternal reentry, even if the aorta is breached on entry.
May 23, 2024
This retrospective study used KROK registry data from Poland between 2012 and 2022 to examine six-year survival after treatment for atrial fibrillation (AF), comparing no treatment, surgical ablation (SA), left atrial appendage occlusion (LAAO), or SA plus LAAO. 33,949 patients were included in the final analysis.
May 23, 2024
The NOTION-2 trial aimed to compare transcatheter aortic valve implantation (TAVI) with surgical aortic valve replacement (SAVR) in low-risk patients less than 75 years old, including with both tricuspid and bicuspid aortic stenosis (AS).
May 23, 2024
This week on The Beat, Editor in Chief Joel Dunning introduces the new DV5 Intuitive Da Vinci robot. He talks about the benefits of this technology and demonstrates some of its new features.